531739 GENNEX

Gennex Laboratories Share Price

₹17.21 -0.27 (-1.54%)

21 Dec, 2024 18:07

SIP TrendupStart SIP in GENNEX

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -10.46%
  • Over 3 Month -31.6%
  • Over 6 Month + 7.09%
  • Over 1 Year + 2.08%
SIP Lightning

Smart Investing Starts Here Start SIP with Gennex Laboratories for Steady Growth!

Invest Now

Gennex Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Gennex Laboratories Financials

Gennex Laboratories Technicals

EMA & SMA

Current Price
₹17.21
-0.27 (-1.54%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹18.31
  • 50 Day
  • ₹19.25
  • 100 Day
  • ₹19.20
  • 200 Day
  • ₹18.05

Resistance and Support

17.31 Pivot Speed
  • R3 18.37
  • R2 18.07
  • R1 17.61
  • S1 16.85
  • S2 16.55
  • S3 16.09

What's your outlook on Gennex Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gennex Laboratories has an operating revenue of Rs. 112.52 Cr. on a trailing 12-month basis. An annual revenue growth of 32% is outstanding, Pre-tax margin of 19% is great, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 17 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Gennex Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Others
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-14 Quarterly Results

Gennex Laboratories F&O

Gennex Laboratories Shareholding Pattern

18.42%
59%
22.58%

About Gennex Laboratories

  • NSE Symbol
  • GENNEX
  • BSE Symbol
  • 531739
  • Managing Director
  • Mr. Arihant Baid
  • ISIN
  • INE509C01026

Similar Stocks to Gennex Laboratories

Gennex Laboratories FAQs

Gennex Laboratories share price is ₹17 As on 21 December, 2024 | 17:53

The Market Cap of Gennex Laboratories is ₹304 Cr As on 21 December, 2024 | 17:53

The P/E ratio of Gennex Laboratories is 18.2 As on 21 December, 2024 | 17:53

The PB ratio of Gennex Laboratories is 1.8 As on 21 December, 2024 | 17:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23